A cryptic site in class 5 epitope of SARS-CoV-2 RBD maintains highly conservation across natural isolates

Comprehensive Overview of Broadly Neutralizing Antibodies against SARS-CoV-2 Variants

Risedronate-functionalized manganese-hydroxyapatite amorphous particles: A potent adjuvant for subunit vaccines and cancer immunotherapy

Rational design of a cross-type HPV vaccine through immunodominance shift guided by a cross-neutralizing antibody

Molecular engineering tools for the development of vaccines against infectious diseases: current status and future directions

Structural basis for broad neutralization of human antibody against Omicron sublineages and evasion by XBB variant

Two antibodies show broad, synergistic neutralization against SARS-CoV-2 variants by inducing conformational change within the RBD

Risedronate-Functionalized Manganese-Calcium Phosphate Nanoparticles: A Potent Adjuvant for Subunit Vaccines and Cancer Immunotherapy

Structure and proposed DNA delivery mechanism of a marine roseophage

Critical Residues Involved in the Coassembly of L1 and L2 Capsid Proteins of Human Papillomavirus 16

Truncated glycoprotein E of varicella-zoster virus is an ideal immunogen for <i>Escherichia coli</i>-based vaccine design

Current progress in the development of prophylactic and therapeutic vaccines

Omics-guided bacterial engineering of Escherichia coli ER2566 for recombinant protein expression

Characterization of an Escherichia coli-derived triple-type chimeric vaccine against human papillomavirus types 39, 68 and 70

A bacterially expressed triple-type chimeric vaccine against human papillomavirus types 51, 69, and 26

Genetic engineering of baculovirus-insect cell system to improve protein production

Structural basis for the synergistic neutralization of coxsackievirus B1 by a triple-antibody cocktail

Identification of a cross-neutralizing antibody that targets the receptor binding site of H1N1 and H5N1 influenza viruses

Endodomain truncation of the HIV-1 envelope protein improves the packaging efficiency of pseudoviruses

Baculovirus Display of Varicella-Zoster Virus Glycoprotein E Induces Robust Humoral and Cellular Immune Responses in Mice

A Bacterially Expressed SARS-CoV-2 Receptor Binding Domain Fused With Cross-Reacting Material 197 A-Domain Elicits High Level of Neutralizing Antibodies in Mice

Structures of pseudorabies virus capsids

A stepwise docking molecular dynamics approach for simulating antibody recognition with substantial conformational changes

Engineering for an HPV 9-valent vaccine candidate using genomic constitutive over-expression and low lipopolysaccharide levels in Escherichia coli cells

Cross-neutralizing antibodies bind a SARS-CoV-2 cryptic site and resist circulating variants

Structural Basis for the Shared Neutralization Mechanism of Three Classes of Human Papillomavirus Type 58 Antibodies with Disparate Modes of Binding

Cryo-EM structures reveal the molecular basis of receptor-initiated coxsackievirus uncoating

Structural characterization of a neutralizing mAb H16.001, a potent candidate for a common potency assay for various HPV16 VLPs

Genome re-sequencing and reannotation of the Escherichia coli ER2566 strain and transcriptome sequencing under overexpression conditions

Rational design of a multi-valent human papillomavirus vaccine by capsomere-hybrid co-assembly of virus-like particles

Recent Progress on the Versatility of Virus-Like Particles

Identification of Antibodies with Non-overlapping Neutralization Sites that Target Coxsackievirus A16

Demonstration of real-time and accelerated stability of hepatitis E vaccine with a combination of different physicochemical and immunochemical methods

SARS-CoV-2 spike produced in insect cells elicits high neutralization titres in non-human primates

Viral neutralization by antibody-imposed physical disruption

HIV-1 Membrane-Proximal External Region Fused to Diphtheria Toxin Domain-A Elicits 4E10-Like Antibodies in Mice

Construction of a bacterial surface display system based on outer membrane protein F

Hepatitis E vaccine candidate harboring a non-particulate immunogen of E2 fused with CRM197 fragment A

Characterization of native-like HIV-1 gp140 glycoprotein expressed in insect cells

Neutralization sites of human papillomavirus-6 relate to virus attachment and entry phase in viral infection

Atomic structures of enterovirus D68 in complex with two monoclonal antibodies define distinct mechanisms of viral neutralization

Rational design of a triple-type human papillomavirus vaccine by compromising viral-type specificity

T=4 Icosahedral HIV-1 Capsid As an Immunogenic Vector for HIV-1 V3 Loop Epitope Display

N-terminal truncations on L1 proteins of human papillomaviruses promote their soluble expression in Escherichia coli and self-assembly in vitro

Identification of Strategic Residues at the Interface of Antigen-Antibody Interactions by In Silico Mutagenesis

Characterization of capsid protein (p495) of hepatitis E virus expressed ID in Escherichia coli and assembling into particles in vitro

Expression, Purification and Characterization of Hiv-1 Capsid Precursor Protein p41

Characterization and epitope mapping of a panel of monoclonal antibodies against HIV-1 matrix protein

Characterization of an Escherichia coil-derived human papillomavirus type 16 and 18 bivalent vaccine

Bacterially expressed human papillomavirus type 6 and 11 bivalent vaccine: Characterization, antigenicity and immunogenicity

Stop codon mutagenesis for homogenous expression of human papillomavirus L1 protein in Escherichia coli

Antiviral Therapy by HIV-1 Broadly Neutralizing and Inhibitory Antibodies

A shared N-terminal hydrophobic tail for the formation of nanoparticulates

The C-Terminal Arm of the Human Papillomavirus Major Capsid Protein Is Immunogenic and Involved in Virus-Host Interaction

Molecular insights into the inhibition of HIV-1 infection using a CD4 domain-1-specific monoclonal antibody

Structure of a Novel Shoulder-to-Shoulder p24 Dimer in Complex with the Broad-Spectrum Antibody A10F9 and Its Implication in Capsid Assembly

Hepatitis E virus capsid protein assembles in 4M urea in the presence of salts

The enhancement of RNAi against HIV in vitro and in vivo using H-2K(k) protein as a sorting method

Development of a hepatitis delta virus antibody assay for study of the prevalence of HDV among individuals infected with hepatitis B virus in China

Structural basis for the neutralization and genotype specificity of hepatitis E virus

Homology model and potential virus-capsid binding site of a putative HEV receptor Grp78

Antibody reactivity of conformational peptide mimics of a conserved H5N1 neutralization site in different fusion proteins

Tetracysteine as a Reporter for Gene Therapy

Dimerization of Hepatitis E Virus Capsid Protein E2s Domain Is Essential for Virus-Host Interaction

Mutational analysis of essential interactions involved in the assembly of hepatitis E virus capsid

Selection of a peptide mimicking neutralization epitope of hepatitis E virus with phage peptide display technology

Evaluation of antibody-based and nucleic acid-based assays for diagnosis of hepatitis E virus infection in a rhesus monkey model